Yep, there’s a pattern here for sure. Seems like we have a bunch of treatments that nearly, kind of, sort of show promise but never in line with the objectives of the specific tests required to gain approval. Always ‘didn’t get approved, but we showed this or that’. Too many things going on, placing bets all over the place but can’t nail one shut... disappointing day. Gotta question management strategy, planning and approval methodologies. Something isn’t working!!
What talking about IBS today?, page-5
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.01 |
Change
0.030(3.06%) |
Mkt cap ! $1.167B | |||
| Open | High | Low | Value | Volume |
| $1.01 | $1.04 | 99.0¢ | $2.503M | 2.458M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 9 | 29185 | $1.01 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.01 | 32021 | 10 |
View Market Depth
| Last trade - 12.02pm 16/08/2024 (20 minute delay) ? |
| MSB (ASX) Chart |